Opko Health, Inc.
OPK
$1.13
$0.021.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.18% | -19.16% | -12.65% | -13.93% | -13.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.18% | -19.16% | -12.65% | -13.93% | -13.66% |
| Cost of Revenue | -26.17% | -9.43% | -18.75% | -10.91% | -28.40% |
| Gross Profit | 7.54% | -42.37% | 74.44% | -30.87% | 98.71% |
| SG&A Expenses | -17.74% | -16.12% | -45.21% | -13.40% | -15.79% |
| Depreciation & Amortization | -4.51% | -6.34% | -4.41% | -4.78% | -7.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.30% | -11.18% | -26.96% | -11.10% | -11.44% |
| Operating Income | 24.05% | -34.68% | 50.11% | 2.74% | 6.02% |
| Income Before Tax | 16.93% | -234.15% | -14.44% | -1,435.38% | 11.78% |
| Income Tax Expenses | -5.89% | -174.77% | -15.85% | -4,928.21% | -327.41% |
| Earnings from Continuing Operations | 18.88% | -322.83% | -13.09% | -1,340.48% | 17.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.88% | -322.83% | -13.09% | -1,340.48% | 17.38% |
| EBIT | 24.05% | -34.68% | 50.11% | 2.74% | 6.02% |
| EBITDA | 34.03% | -161.32% | 62.97% | 1.50% | 4.32% |
| EPS Basic | 28.20% | -297.10% | -22.35% | -1,172.97% | 13.04% |
| Normalized Basic EPS | 29.13% | -131.20% | 54.77% | -1,256.84% | 9.51% |
| EPS Diluted | 28.20% | -335.23% | -12.58% | -1,172.97% | 13.04% |
| Normalized Diluted EPS | 29.13% | -143.87% | 35.22% | -1,256.84% | 9.51% |
| Average Basic Shares Outstanding | 13.00% | 13.11% | 11.88% | 13.02% | -4.99% |
| Average Diluted Shares Outstanding | 13.00% | -19.57% | -21.88% | 13.02% | -4.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |